Division of Medical Oncology, The Cancer Institute of New Jersey
New Brunswick, NJ, USA
Hatem E. Sabaawy, M.D., Ph.D., is a Principal Investigator at the Cancer Institute of New Jersey, Director, Production Facility for Cell and Gene therapy, and an Assistant professor of Medicine, Rutgers/Robert Wood Johnson Medical School since 2008. He completed his medical residency in Hematology and graduate training at Cairo University and New York Medical College, Valhalla, NY, USA in 2003. He then completed a fellowship in Transplantation Branch of the National Cancer Institute at NIH, Bethesda, MD in 2007.
His research focuses on studying stem cell biology, cancer stem cells and drug discovery. By performing chemical and genetic modifier screens using tumor-prone zebrafish, mutant genes or small molecules that suppress or modify tumor progression can be discovered. The long-term objectives are to dissect stem cell developmental pathways subverted in normal development, and how cancer stem cells divert from these regulatory pathways. Parallel research efforts focus on cell therapy and transplantation in regenerative medicine.